Cara Therapeutics, Inc. (CARA)
15.96
-0.69 (-4.14%)
Inactive · Last trade price on Apr 15, 2025

Cara Therapeutics Revenue

In the year 2024, Cara Therapeutics had annual revenue of $7.14M, down -65.96%. Cara Therapeutics had revenue of $1.46M in the quarter ending December 31, 2024, a decrease of -51.56%.

Revenue (ttm)
$7.14M
Revenue Growth
-65.96%
P/S Ratio
3.40
Revenue / Employee
$713,700
Employees
10
Market Cap
24.33M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.14M-13.83M-65.96%
Dec 31, 202320.97M-20.90M-49.92%
Dec 31, 202241.87M18.84M81.81%
Dec 31, 202123.03M-112.05M-82.95%
Dec 31, 2020135.08M115.20M579.28%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro